Skip to main content
DORSAVI LTD logo

DORSAVI LTD — Investor Relations & Filings

Ticker · DVL ISIN · AU000000DVL0 ASX Professional, scientific and technical activities
Open in API
Filings indexed 703 across all filing types
Latest filing 2026-05-17 Regulatory Filings
Country AU Australia
Listing ASX DVL

About DORSAVI LTD

https://dorsavi.com/

DorsaVi Ltd specializes in the development of wearable sensor technology and movement analysis software. The company provides clinical-grade solutions designed to monitor and analyze human movement with high precision. Its core product suites include ViMove, which assists clinicians in assessing and managing patient recovery; ViSafe, which helps organizations reduce workplace injury risks through ergonomic assessments; and ViPerform, tailored for elite sports performance and injury prevention. By utilizing wireless sensors and sophisticated algorithms, the technology captures objective data on posture, muscle activity, and movement patterns in real-world environments. These insights enable healthcare professionals, employers, and athletic trainers to make data-driven decisions to improve physical outcomes and safety.

Recent filings

Filing Released Lang Actions
DVL Marks Major Milestone to 22nm RRAM Commercialisation 10 pages 847.5KB
Regulatory Filings Classification · 70% confidence The document is an ASX announcement describing a technical milestone in RRAM materials qualification and commercialisation pathway. It is a corporate press release providing a business update rather than an actual financial report, investor presentation, or regulatory/legal filing of a specific type. It does not fit categories like earnings release, capital raise, or M&A activity. As a general announcement filed via ASX without substantive financial statements or shareholder action, it falls into the fallback category for miscellaneous regulatory announcements (RNS).
2026-05-17 English
DVL May 2026 Investor Webinar 2 pages 358.9KB
Regulatory Filings Classification · 80% confidence The document is an ASX announcement about an upcoming investor webinar, inviting registration and questions. It does not contain substantive financial data, results, or detailed presentation slides. It is not a financial report, management discussion, or official filings like dividends or share actions. Rather, it is a general regulatory announcement about a corporate event. Therefore, it best fits the Regulatory Filings category (RNS).
2026-05-17 English
DVL Advances US Dept of Defense Military Injury Program 10 pages 1.0MB
Regulatory Filings Classification · 82% confidence The document is an ASX announcement/press release about a contract renewal and strategic research program. It does not present financial results, management changes, dividends, or detailed report content. It is a general corporate update without substantive financial statements or reporting requirements. Therefore it falls under the catch‐all Regulatory Filings (RNS) category.
2026-05-10 English
DVL advances modular ultra-edge hardware platform 10 pages 810.5KB
Regulatory Filings
2026-05-05 English
Quarterly Activities/Appendix 4C Cash Flow Report 22 pages 1.3MB
Regulatory Filings
2026-04-29 English
DVL Expands Robotics Strategy into Next-Gen Exoskeletons 9 pages 708.4KB
Regulatory Filings
2026-04-27 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.